
戈利昔替尼 新

规格 | 价格(CNY) | 是否现货 | 购买咨询 |
---|---|---|---|
10.00 mg | ¥2600.00 | In-stock | 购买咨询 |
50.00 mg | ¥7000.00 | In-stock | 购买咨询 |
100.00 mg | ¥11000.00 | In-stock | 购买咨询 |
全国免运费!免费咨询:400-099-8200 或 手机联系:13472751340
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 2091134-68-6 | 货号 | BCP36112 |
中文名 | 戈利昔替尼 | ||
英文名 | Golidocitinib | ||
中文别名 | |||
英文别名 | AZD4205; AZD 4205;AZD-4205; | ||
SMILES | CC(C(=O)NC1=CC=CC2=C1NC=C2C3=NC(=NC=C3)NC4=CN(N=C4OC)C)N5CCN(CC5)C | ||
化学名称 | |||
分子式 | C25H29N9O2 | 分子量 | 487.57 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Golidocitinib is an orally available inhibitor of Janus-associated kinase 1 (JAK1), with potential antineoplastic activity. Upon oral administration, golidocitinib inhibits JAK-dependent signaling and may lead to an inhibition of cellular proliferation in JAK1-overexpressing tumor cells. The JAK-STAT (signal transducer and activator of transcription) signaling pathway is a major mediator of cytokine activity and is often dysregulated in a variety of tumor cell types. Additionally, JAK1 may be a primary driver of STAT3 phosphorylation and signaling, which plays a role in neoplastic transformation, resistance to apoptosis, tumor angiogenesis, metastasis, immune evasion, and treatment resistance. |
相关产品推荐
查看更多 >Tags:Golidocitinib 供应商,Golidocitinib 购买,Golidocitinib 生产,Golidocitinib 批量,Golidocitinib 供应,Golidocitinib 订购,Golidocitinib 采购